Solubility, inhibited growth and dissolution kinetics of calcium oxalate crystals in solutions, containing hippuric acid
- PMID: 8342252
- DOI: 10.1007/BF00590034
Solubility, inhibited growth and dissolution kinetics of calcium oxalate crystals in solutions, containing hippuric acid
Abstract
An analysis of crystal growth and dissolution of slightly soluble salts in physiological solutions in the presence of complexing ions was carried out, simulating conditions typical in human urine. It was found that hippuric acid, a normal physiological constituent of urine, acts at increased concentrations as a dissolving agent with respect to calcium oxalate (CaOx) and CaOx calculi. The kinetics of dissolution of crystalline CaOx calculi in physiological solutions containing hippuric acid at different concentrations were studied, using the change in the Archimedean weight of samples immersed in the solution. Analysis of the experimental results enabled the determination of the increased solubility of CaOx in the presence of hippuric acid and the quantitative characterization of this substance as a new and promising agent for dissolving CaOx calculi in human urine. The possible effect of hippuric acid as a natural regulator of CaOx supersaturation and crystallization in human and mammalian urine is also discussed.
Similar articles
-
Hippuric acid as a significant regulator of supersaturation in calcium oxalate lithiasis: the physiological evidence.Biomed Res Int. 2013;2013:374950. doi: 10.1155/2013/374950. Epub 2013 Nov 7. Biomed Res Int. 2013. PMID: 24307993 Free PMC article.
-
Hippuric acid as a modifier of calcium oxalate crystallisation.Clin Chem Lab Med. 2001 Mar;39(3):218-22. doi: 10.1515/CCLM.2001.034. Clin Chem Lab Med. 2001. PMID: 11350018
-
Influence of the lysine on the calcium oxalate renal calculi.Int Urol Nephrol. 2014 Mar;46(3):593-7. doi: 10.1007/s11255-013-0532-x. Epub 2013 Sep 21. Int Urol Nephrol. 2014. PMID: 24057683
-
Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.Urolithiasis. 2017 Feb;45(1):43-56. doi: 10.1007/s00240-016-0953-y. Epub 2016 Nov 29. Urolithiasis. 2017. PMID: 27900407 Review.
-
The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.Scanning Microsc. 1991 Sep;5(3):689-95; discussion 696. Scanning Microsc. 1991. PMID: 1808706 Review.
Cited by
-
Inhibition of calcium oxalate crystallisation in vitro by an extract of Bergenia ciliata.Arab J Urol. 2013 Jun;11(2):187-92. doi: 10.1016/j.aju.2013.04.001. Epub 2013 May 9. Arab J Urol. 2013. PMID: 26558080 Free PMC article.
-
Discovery of l-Lysine Dioxalate (LH1513) as a Novel Inhibitor of Calcium Oxalate Crystallization for Hyperoxaluria.ACS Med Chem Lett. 2024 Nov 4;15(11):2005-2011. doi: 10.1021/acsmedchemlett.4c00423. eCollection 2024 Nov 14. ACS Med Chem Lett. 2024. PMID: 39563801
-
Hippuric acid as a significant regulator of supersaturation in calcium oxalate lithiasis: the physiological evidence.Biomed Res Int. 2013;2013:374950. doi: 10.1155/2013/374950. Epub 2013 Nov 7. Biomed Res Int. 2013. PMID: 24307993 Free PMC article.